News from rxi pharmaceuticals corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

07:02 ET

RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily...

Jun 02, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

May 28, 2015, 07:00 ET

RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in...

May 27, 2015, 16:10 ET

RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in...

May 27, 2015, 07:02 ET

RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

May 26, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

May 13, 2015, 07:05 ET

RXi Pharmaceuticals Reports First Quarter 2015 Financial Results and Business Highlights

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...

May 11, 2015, 07:02 ET

RXi Pharmaceuticals Presented Promising New Data with Self-delivering RNAi Compounds Targeting Tyrosinase and Collagenase

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Apr 29, 2015, 07:02 ET

RXi Pharmaceuticals to Webcast First Quarter 2015 Financial Results on Wednesday, May 13, 2015

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in...

Apr 27, 2015, 07:02 ET

RXi Pharmaceuticals Announces Upcoming Presentations at Leading Partnering and Scientific Conferences

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily...

Apr 17, 2015, 07:50 ET

RXi Pharmaceuticals Receives Orphan Drug Designation for Samcyprone™ from the U.S. FDA for the Treatment of Malignant Melanoma Stage IIb to IV

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies...

Mar 30, 2015, 07:02 ET

RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Mar 27, 2015, 09:02 ET

RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer

 RXi Pharmaceuticals Corporation (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive...

Mar 23, 2015, 07:02 ET

RXi Pharmaceuticals Reports Positive Advancements in its Dermatology Programs at the Occasion of the 73rd Annual Meeting of the American Academy of Dermatology

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing...

Mar 16, 2015, 07:02 ET

RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2014 Financial Results on Monday, March 30, 2015

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics...

Mar 11, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 73rd Annual Meeting of the American Academy of Dermatology

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapeutics, that...

Feb 05, 2015, 07:02 ET

RXi Pharmaceuticals Announces Closing of the Exclusive Global Licensing Agreement to Samcyprone™ with Hapten Pharmaceuticals

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies addressing...

Feb 03, 2015, 07:02 ET

RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Feb 02, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies...

Jan 05, 2015, 07:02 ET

RXi Pharmaceuticals to Present at the 7th Annual Biotech Showcase™

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative...